The pioneering DNA testing firm has been struggling to stay afloat financially despite ambitious ventures to provide health ...

If automation is to become a key partner in experiment design and a core component of modern lab infrastructure, it is ...

Bettersize's upcoming webinar will delve into particle size and zeta potential, showcasing their importance in pharmaceutical development and product quality.

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn ...

GSK has reported positive results from its phase II trial for an mRNA seasonal influenza vaccine candidate, showing strong immune responses again ...

AstraZeneca (LSE: AZN) is a UK stock on fine form. It recently notched a 52-week high of 13,290p not long after the ...

Can iTeos and GSK solve TIGIT’s troubles? Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant… Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more Gilead’s ...

Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell ...

Moderna jolted investors by pushing back its profitability forecast two years, to 2028, and announcing a $1.1 billion cut in R&D spending.

Elodie Goullin Peribere has been elevated to the role of Senior Marketing Director, Great-Britain & Ireland at The Coca-Cola ...

Kieran Reals, Hilary Thomas and James Mucklow discuss why clinical trials need adaptive designs and patient segmentation for ...

Beyond Leather Materials has partnered with Covestro to develop LEAP®, a sustainable leather alternative made from over 85% ...